当前位置: 首页 > 期刊 > 《上海医药》 > 2021年第17期
编号:52504
国外促进生物医药产业创新发展监管制度的启示
http://www.100md.com 2021年10月9日 2021年第17期
1国外促进生物医药产业创新发展的监管举措,2对促进我国生物医药产业发展监管的启示,3结语
     于玲莉 杨绎雯 刘朋

    摘 要 近年来,生物医药产业已成为世界主要发达国家争相布局的重要领域,各国也相继出台了诸多加快产业发展的监管举措。本文将从国外鼓励创新研发、促进成果转化和加快创新产品上市等方面的举措展开研究,希望为今后在我国制定促进生物医药产业发展的监管制度提供借鉴与参考。

    关键词 创新 药品监管 生物医药产业

    中图分类号:R951 文献标志码:C 文章编号:1006-1533(2021)17-0053-03

    The enlightenment of supervision system abroad for promoting innovation and development of biomedical industry

    YU Lingli1, YANG Yiwen2, LIU Peng1(1. Shanghai Center for Drug Evaluation and Inspection, Shanghai 201203, China; 2. Shanghai Center for Adverse Drug and Medical Device Reaction Monitoring, Shanghai 200040, China)

    ABSTRACT The biopharmaceutical industry has become an important area where the worlds major developed countries compete for layout, and many countries have introduced new regulatory measures to accelerate bio-industrial development in recent years. In this article, we focus on the study of measures adopted by foreign countries to encourage innovation and R&D, to promote the transformation of scientific and technological achievement and to accelerate product development process ......

您现在查看是摘要页,全文长 8613 字符